Falco Reissig

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Pharmaceuticals (Basel, Switzerland)

ChemistryOpen

Cancers

Helmholtz-Zentrum Dresden-Rossendorf

Technische Universität Dresden Fachrichtung Chemie und Lebensmittelchemie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz-Zentrum Dresden-Rossendorf Jan 01 2018

Germany

Doctoral Researcher :: Institute of Radiopharmaceutical Cancer Research

Education History

Technische Universität Dresden Fachrichtung Chemie und Lebensmittelchemie Jan 01 2018

Germany

PHD

Hochschule für Technik und Wirtschaft Dresden Chemieingenieurwesen Mar 01 2016 - Dec 31 2017

Germany

MSC

Hochschule für Technik und Wirtschaft Dresden Chemieingenieurwesen Sep 01 2011 - Feb 28 2015

Germany

BSC

Publications

Santiago Andrés Brühlmann, Martin Walther, Martin Kreller, Falco Reissig, Hans-Jürgen Pietzsch, Torsten Kniess, Klaus Kopka
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Roswitha Runge, Falco Reissig, Nora Herzog, Liane Oehme, Claudia Brogsitter, Joerg Kotzerke
Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Roswitha Runge, Falco Reissig, Nora Herzog, Liane Oehme, Claudia Brogsitter, Joerg Kotzerke
Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Falco Reissig, Constantin Mamat
Strained Ammonium Precursors for Radiofluorinations. ChemistryOpen 11 (6) (2022)
Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig
Efficient Production of the PET Radionuclide 133 La for Theranostic Purposes in Targeted Alpha Therapy Using the 134 Ba(p,2n) 133 La Reaction. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Falco Reissig, David Bauer, Kristof Zarschler, Zbynek Novy, Katerina Bendova, Marie-Charlotte Ludik, Klaus Kopka, Hans-Jürgen Pietzsch, Milos Petrik, Constantin Mamat
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept Study. Cancers 13 (8) (2021)
Janine Steinberg, David Bauer, Falco Reissig, Martin Köckerling, Hans-Jürgen Pietzsch, Constantin Mamat
Modified Calix[4]crowns as Molecular Receptors for Barium. ChemistryOpen 7 (6) (2018)
Janine Steinberg, David Bauer, Falco Reissig, Martin Köckerling, Hans-Jürgen Pietzsch, Constantin Mamat
Modified Calix[4]crowns as Molecular Receptors for Barium. ChemistryOpen 7 (6) (2018)

Falco Reissig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Falco Reissig